Cargando…

Nebulized formoterol: a review of clinical efficacy and safety in COPD

A nebulized formulation of formoterol, Perforomist(®), 20 μg/2 ml, has been available since 2007 for the maintenance treatment of chronic obstructive pulmonary disease (COPD). We review the safety and efficacy data obtained during its development. In a dose-finding study, formoterol inhalation solut...

Descripción completa

Detalles Bibliográficos
Autores principales: Gross, Nicholas J, Donohue, James F
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921690/
https://www.ncbi.nlm.nih.gov/pubmed/20714376